Replies to post #168 on Biotech Values

[DewDiligence]

>> Remember this, many drugs are approved on an accelerated approval basis usually backed with Phase II studies, and a pivotal underway or near completion. TRMS's Fuzeon, and ABT's Kaletra for example...DNA's Avastin too....<<

But the FDA’s accelerated-approval program applies only to the life-threatening conditions of cancer and AIDS. It would take a statutory change by Congress to broaden the accelerated-approval program to include drugs to fight blindness.